AEMD - Aethlon Medical, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue392.073886.572762.417
Cost of Revenue---
Gross Profit392.073886.572762.417
Operating Expenses
Research Development---
Selling General and Administrative6,490.435,271.4064,755.27
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-6,098.357-4,384.834-3,992.853
Income from Continuing Operations
Total Other Income/Expenses Net-904.039-904.039-2,534.365
Earnings Before Interest and Taxes-7,002.396-4,384.834-6,527.218
Interest Expense304.33573.782452.276
Income Before Tax-7,306.726-4,958.616-6,979.494
Income Tax Expense---
Minority Interest-80.967-50.35435.933
Net Income From Continuing Ops-7,276.113-4,872.329-6,797.157
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-7,276.113-4,872.329-6,797.157
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-7,276.113-4,872.329-6,797.157